How Is Kıdney Cancer Followed?

Table of Contents

How Is Kıdney Cancer Followed?

Sometimes this test is done just to see how your kidneys are working rather than to check for cancer. This is a series of x-rays that create a picture of the kidneys. The test uses a special dye that is injected into a blood vessel in the arm. Your doctor will tell you if you need this test and if you need to do anything to prepare before the test. If your doctor says you need this test but you had a reaction to the dye in the past, tell your doctor before you have this test.

Your doctor may also want to repeat urine tests. This test looks for small amounts of blood that you may not be able to see. Blood in the urine is a sign that your cancer has come back. If blood is seen in the urine, another test will likely be used to look more closely at the kidneys.

Your doctor may use one or more of the following tests to check to see if your kidney cancer has come back. Usually, blood tests will be taken at your regular visits to your doctor, rather than just during follow-up visits. In addition, the following tests from time to time may be needed.

After treatment, your doctor will probably want to check to see if your cancer has come back. Regular checkups are very important. If cancer is found, your doctor will be able to find it early when it is most likely to be treated successfully. It is important to follow your doctor’s instructions about follow-up care carefully.

Frequently Asked Questıons

Why are the new oral chemotherapy agents for kıdney cancer generally well tolerated and effectıve regardless of a patıent's chronıc renal faılure, and what role mıght blood dıalysis play ın theır treatment strategy?

Because of their specific pharmacokinetics, the chemotherapy agents for kidney cancer are generally well tolerated by the majority of the oncological patients. Using the new oral kidney cancer chemotherapeutic agents such as Sunitinib, Sorafenib, Temsirolimus, studies have shown that anti-tumor efficacy is not related to the patient’s chronic renal failure. Blood dialysis has no clear indications in renal cancer and would be potentially effective if it might prove its anti-tumor activity. This is the case with Interleukin-2.

What are the sıde effects?

The side effects or, better said, toxic effects observed as a result of the kidney cancer therapy are variable ranging from patient to patient. The effects vary directly proportional to the used chemotherapy dose, the time period of exposure to the ascertained substances, and the general state of health of the patient, and the previous treatments for instance radiotherapy, immunotherapy. The toxic effects are known only as a result of the employed substance’s inhibition procedure on conjunct body organs. These phenomena limit the use of a few chemotherapy agents or better said, it is treated with caution, especially in patients with diminished renal function.

Do the sıde effects of antı-kıdney cancer therapy have a bad ımpact on renal functıons?

At about 50% of the patients, kidney cancer is identified at the first consultation of the patient to a urologist, through renal tumors (without symptoms). Specific to renal tumors are: hematuria, the presence of blood in the urine, backache, hemoptysis, pollakiuria (frequent emission of urine), abdominal mass, erythrocythemia (too many red blood cells in the blood). Other general symptoms can be: asthenia (feeling tired); perspiration especially during the night; dysplasia; severe weight loss.


      

    Share

    reklam ajansları